Shares of Neuland Laboratories Ltd surged by about 10 %, reaching a 52-week high of ₹19,599 in morning trading on Monday, 10 November 2025, following the company’s strong performance for the quarter ended September 2025 (Q2 FY26).
The steep jump was driven by a 201 % year-on-year rise in profit after tax (PAT). Meanwhile revenue rose 63.7 % and EBITDA expanded 138.8 % with margin expansion to 30.4%.
Investors responded positively to the margin improvement and growth acceleration, rewarding the stock with the sharp uptick. The rally reflects renewed confidence that the company’s execution is improving and that it may be poised for stronger earnings growth ahead.
